Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition

POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler

NCT01051817 ·Status: COMPLETED ·Phase: PHASE2

Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP)

NCT03653273 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants

NCT05811416 ·Status: ACTIVE_NOT_RECRUITING

Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)

NCT01405820 ·Status: COMPLETED ·Phase: PHASE2

Multiparametric Assessment to Investigate Prognostic Factors for Disease Evolution a nd Evolutionary Patterns of Cognitive Status in RRMS

NCT05510817 ·Status: RECRUITING ·Phase: NA

A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

NCT02861014 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT05147220 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis

NCT03889639 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis

NCT01433250 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT05156281 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis

NCT03996291 ·Status: COMPLETED ·Phase: PHASE2

Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis

NCT06592703 ·Status: RECRUITING ·Phase: PHASE1

Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)

NCT03073603 ·Status: COMPLETED ·Phase: PHASE4

A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

NCT05658601 ·Status: COMPLETED

Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.

NCT01623596 ·Status: COMPLETED ·Phase: PHASE4

Improved Detection of Multiple Sclerosis Plaques in Inversion Recovery by Optimization of Sequence Parameters

NCT03108573 ·Status: COMPLETED

Monitoring of Multiple Sclerosis (MS) Participants With the Use of Digital Technology (Smartphones and Smartwatches) - A Feasibility Study

NCT02952911 ·Status: COMPLETED ·Phase: NA

Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients

NCT04593927 ·Status: COMPLETED

Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis

NCT00219908 ·Status: TERMINATED ·Phase: PHASE2

A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis

NCT00529581 ·Status: COMPLETED ·Phase: PHASE2

Role of Simvastatin in Relapsing-Remitting Multiple Sclerosis

NCT04178980 ·Status: UNKNOWN ·Phase: PHASE1

Autologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosis

NCT01056471 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice

NCT06251986 ·Status: COMPLETED

Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis

NCT04530318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Comparison of Oral Molecules Preventing Relapses in Multiple Sclerosis

NCT03302442 ·Status: COMPLETED